Literature DB >> 21731583

ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal.

E J Marco1, F E Abidi, J Bristow, W B Dean, P Cotter, R J Jeremy, C E Schwartz, E H Sherr.   

Abstract

We identified a female patient with mental retardation and sensory hyperarousal. She has a de novo paracentric inversion of one X chromosome with completely skewed inactivation of the normal X chromosome. We aimed to identify whether a single gene or gene region caused her cognitive and behavioural impairment and that of others. Fluorescent in situ hybridisation (FISH) showed that the centromeric breakpoint disrupts a single gene: ARHGEF9 (CDC42 guanine nucleotide exchange factor (GEF) 9). We also found that the levels of the ARHGEF9 transcript from the patient are 10-fold less than those found in control samples. ARHGEF9 encodes a RhoGEF family protein: collybistin (hPEM), which is highly expressed in the brain. Collybistin can regulate actin cytoskeletal dynamics and may also modulate GABAergic and glycinergic neurotransmission through binding of a scaffolding protein, gephyrin, at the synapse. This potential dual role may explain both the mental retardation and hyperarousal observed in our patient.

Entities:  

Year:  2009        PMID: 21731583      PMCID: PMC3028392          DOI: 10.1136/bcr.06.2009.1999

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

Review 1.  Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton.

Authors:  A Hall; C D Nobes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-07-29       Impact factor: 6.237

2.  Building inhibitory synapses: exchange factors getting into the act? [ comment].

Authors:  J R Fallon
Journal:  Nat Neurosci       Date:  2000-01       Impact factor: 24.884

3.  A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation.

Authors:  R Zemni; T Bienvenu; M C Vinet; A Sefiani; A Carrié; P Billuart; N McDonell; P Couvert; F Francis; P Chafey; F Fauchereau; G Friocourt; V des Portes; A Cardona; S Frints; A Meindl; O Brandau; N Ronce; C Moraine; H van Bokhoven; H H Ropers; R Sudbrak; A Kahn; J P Fryns; C Beldjord; J Chelly
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 4.  Clinical and molecular contributions to the understanding of X-linked mental retardation.

Authors:  R E Stevenson; C E Schwartz
Journal:  Cytogenet Genome Res       Date:  2002       Impact factor: 1.636

5.  Automated splicing mutation analysis by information theory.

Authors:  Vijay K Nalla; Peter K Rogan
Journal:  Hum Mutat       Date:  2005-04       Impact factor: 4.878

Review 6.  XLMR genes: update 2000.

Authors:  P Chiurazzi; B C Hamel; G Neri
Journal:  Eur J Hum Genet       Date:  2001-02       Impact factor: 4.246

7.  Early and later replication patterns of increased resolution in human lymphocyte chromosomes.

Authors:  B Meer; H Hameister; M Cerrillo
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

8.  PAK3 mutation in nonsyndromic X-linked mental retardation.

Authors:  K M Allen; J G Gleeson; S Bagrodia; M W Partington; J C MacMillan; R A Cerione; J C Mulley; C A Walsh
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

9.  Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation.

Authors:  K Kutsche; H Yntema; A Brandt; I Jantke; H G Nothwang; U Orth; M G Boavida; D David; J Chelly; J P Fryns; C Moraine; H H Ropers; B C Hamel; H van Bokhoven; A Gal
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

10.  Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study.

Authors:  W J Meerding; L Bonneux; J J Polder; M A Koopmanschap; P J van der Maas
Journal:  BMJ       Date:  1998-07-11
View more
  2 in total

1.  A novel de novo hemizygous ARHGEF9 mutation associated with severe intellectual disability and epilepsy: a case report.

Authors:  Tong Qiu; Qian Dai; Qiu Wang
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

2.  Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.

Authors:  Gemma L Carvill; Sinéad B Heavin; Simone C Yendle; Jacinta M McMahon; Brian J O'Roak; Joseph Cook; Adiba Khan; Michael O Dorschner; Molly Weaver; Sophie Calvert; Stephen Malone; Geoffrey Wallace; Thorsten Stanley; Ann M E Bye; Andrew Bleasel; Katherine B Howell; Sara Kivity; Mark T Mackay; Victoria Rodriguez-Casero; Richard Webster; Amos Korczyn; Zaid Afawi; Nathanel Zelnick; Tally Lerman-Sagie; Dorit Lev; Rikke S Møller; Deepak Gill; Danielle M Andrade; Jeremy L Freeman; Lynette G Sadleir; Jay Shendure; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Nat Genet       Date:  2013-05-26       Impact factor: 38.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.